Max-Eder Research Group Leader & Physician Scientist @NCT_HD @DKFZ @DKTK @Uniklinik_HD TRYTRAC @CancerCoreEU Previously DFG PostDoc @Uchicago Gajewski lab.
Heidelberg
Joined June 2022
- Tweets224
- Following248
- Followers399
- Likes4.8K
Pinned Tweet
Very excited to share our Focus in @SciImmunology 📢 “CXCL9 and CXCL10 bring the heat to tumors” 🔥
It underlines how chemokines are important in bringing key immune cells into the TME and thereby make tumors more responsive to immunotherapy.
science.org/doi/10.1126/scii…
Robin Reschke retweeted
🧪 Wie lassen sich Nebenwirkungen von Immuntherapien bei Hautkrebs besser verstehen und behandeln? Daran forscht PD Dr. Robin Reschke – mit dem Ziel, neue molekulare Angriffspunkte für personalisierte Therapien zu finden. 🎯 @DrRobinReschke ➡️ sohub.io/u2ez
Robin Reschke retweeted
#CCEAM26 marked a milestone as we celebrated the 10th CCE Annual Meeting, hosted by @karolinskainst
Enhancing collaboration and exchange 💡
👏 Thank you to the organizing team and all participants!
➡️ Looking ahead to #CCEAM27 at @DKFZ/@NCT_HD
🔗 cancercoreeurope.eu/cancer-c…
Robin Reschke retweeted
Well-deserved recognition 👏
Congratulations, @DrRobinReschke!
Honored to Receive the Inaugural Early Career Investigator Award from CCE - PD Dr. Robin Reschke
@DrRobinReschke @CancerCoreEU
oncodaily.com/voices/robin-r…
#OncoDaily #Oncology #Cancer #Health #Medicine #MedX #MedTwitter
Robin Reschke retweeted
Learning Through Teaching and Patient Perspectives in Skin Cancer - Robin Reschke
@DrRobinReschke
oncodaily.com/voices/robin-r…
#OncoDaily #Oncology #Cancer #Health #Medicine #MedX #MedTwitter
Robin Reschke retweeted
🌟Calling for Papers🌟
📚New #SpecialIssue: Clinical, Immune, and Microbial Markers of Response to Systemic Therapy in #SkinCancer
👨🔬Guest Editor: Dr. Robin Reschke @DrRobinReschke
🔗Find Out More: mdpi.com/journal/cancers/spe…
⏰Submission Deadline: 14 March 2027
Robin Reschke retweeted
Special Issue Open on Skin Cancer Therapy Response and Biomarkers - Robin Reschke (@DrRobinReschke)
oncodaily.com/voices/robin-r…
#OncoDaily #Oncology #Cancer #Health #Medicine #MedX #SkinCancer
Robin Reschke retweeted
New #JITC article: Autoantibodies as predictors for immune-related adverse events in checkpoint inhibition therapy of metastatic melanoma jitc.bmj.com/content/14/1/e0…
@DrRobinReschke @PetraBudde
Robin Reschke retweeted
Can We Predict Immunotherapy Toxicity Before Treatment Starts? - @DrRobinReschke
oncodaily.com/voices/robin-r…
#Cancer #Medicine #Health #Oncology #OncoDaily #Immunotherapy #MedX #MedNews #MedEd
🧪✨ Can we predict immunotherapy toxicity before treatment starts?
Our new study says: yes.
Baseline autoantibody profiles predict irAEs & colitis in melanoma—and differ by PD-1 vs CTLA-4 therapy.
Toward safer, personalized checkpoint inhibition. 🚀
jitc.bmj.com/content/14/1/e0…
Robin Reschke retweeted
Fully Funded Postdoctoral Positions Available at DKFZ, EMBL, and the University of Heidelberg - @DrRobinReschke
oncodaily.com/voices/robin-r…
#Cancer #Medicine #Health #Oncology #OncoDaily #MedX #MedNews #MedEd
Fully funded Post-Doc @Heidelberg
Interested in cutting edge spatial biology methods 🗺️, computational biology 💻, cancer neuroscience 🧬, microbiome 🦠 and tumor immunology are encouraged to apply for projects 22 and 29.
You can directly apply with me🤩
health-life-sciences.de/oppo…
We invite applications for fully funded inter-institutional postdoctoral positions hosted by DKFZ, EMBL, the University of Heidelberg, and other. Interested candidates are encouraged to apply to projects 22 and 29 and others 😜
health-life-sciences.de/oppo…
Robin Reschke retweeted
🎄Wir wünschen euch schöne Feiertage!🎄
✨ Danke für eure tolle Unterstützung in diesem Jahr 💝
#FroheWeihnachten #MerryChristmas2025
New podcast alert🚨✨it was nice to take a moment at the end of the year to reflect on the past, both professionally and personally. 🎄If anyone is looking for a new podcast to listen to over the Christmas days, OnCoffee is definitely worth tuning into. youtu.be/vYEbOV4CP7M?si=m32a…
Robin Reschke retweeted
Honored to Join DKFZ Visit to Gustave Roussy - Robin Reschke (@DrRobinReschke)
@GustaveRoussy
oncodaily.com/voices/robin-r…
#OncoDaily #Oncology #Cancer #Health #Medicine #MedX
Robin Reschke retweeted
PREDICT Study Insights at HARPOON 2025 - @DrRobinReschke
oncodaily.com/voices/robin-r…
#Cancer #OncoDaily #Oncology #MedEd #MedTwitter #MedX #MedOnc @CancerWorldmag
🌊 HARPOON Conference 2025 — PREDICT Study 🎯
Happy to play a small part in this high-quality DKFZ/DKTK/NCT meeting and to share our latest results from the PREDICT study, which I’m proud to co-lead with Prof. Jessica Hassel.
#HARPOON #DKFZ #DKTK #NCT #cancercoreeurope
Robin Reschke retweeted
Honored to Welcome TRYTRAC Fellows to Heidelberg for the 2nd Cancer Core Europe Meeting - @DrRobinReschke
oncodaily.com/voices/robin-r…
#Health #Oncology #OncoDaily #Medicine #Cancer @CancerWorldmag
Robin Reschke retweeted
Heidelberg University with 16 “Highly Cited Researchers”
@DrRobinReschke
oncodaily.com/voices/heidelb…
#OncoDaily #Oncology #Cancer #Health #Medicine #MedX
